On this week’s BioTech Nation, Dr. Gunn speaks with Dr. Ignacio Pino, the CEO of the next generation proteomics company, CDI, located in Mayaguez, Puerto Rico.
On this week’s BioTech Nation, Dr. Gunn speaks with Daniel Zurr, CEO of Quark Pharmaceuticals. Their approach uses a part of the immune system called siRNA, and they are working on treatments for kidney damage following open heart surgery, damage to kidneys during the transplantation process, and sudden vision loss.
On this week’s BioTech Nation, Dr. Gunn speaks with the promise and challenges of cancer immunotherapy. Dr. Gunn speaks with Dr. Sean McCarthy, the CEO of CytomX Therapeutics.
On this week’s BioTech Nation, in the Pediatric area, diagnosing some behavioural problems and mental disorders by testing the immune system. Dr. Craig Shimasaki, the CEO of Moleculera Labs, explains their test and the science behind it.
On this week’s BioTech Nation, correcting the underrepresentation of Latinos in testing pharmaceuticals and directly addressing the Zika virus in humans. Dr. Kosmas Kretsos, the Executive Director of the Puerto Rico Consortium for Clinical Investigation (PRCCI) describes the efforts underway in Puerto Rico.
On this week’s BioTech Nation, Dr. Steve Mento, the CEO of Conatus Pharmaceuticals, talks about their efforts to treat NASH – Non Alcoholic Fatty Liver Disease, and Bill Newell, the CEO of Sutro Biopharma, fills us in on their strategic approach to treating cancer. Their first target? B-cell lymphomas.
On this week’s BioTech Nation, STEVE HURST, the President & CEO of Savant HWP. We hear about an emergent treatment for cocaine addiction, work in the tropical disease Leishmaniasis, and the unexpected link between addiction to dopamine in Parkinson’s patients.
On this week’s BioTech Nation, a new approach to achieving health with a compromised immune system. Dr. DAVID JOHNSON is the Founder, President & CEO of GigaGen. And critically-ill newborns get the genetic information they need … and fast. GAVIN STONE is the Vice President for Marketing at EdicoGenome in San Diego.
On this week’s BioTech Nation, upping the game for wearables – NOAH KONIG from Cambridge Cognition and BEN FEHNERT from The CTRL Group, talk about their new venture, Cognition Kit. Measuring cognition along with the impact of medications, and opening up these measurements for others to develop applications.